Steve Hahn, MD, professor and chair of radiation oncology at the University of Pennsylvania School of Medicine, details advances in our understanding of proton therapy. This innovative cancer treatment could be of great benefit to patients, but, Dr. Hahn cautions, we're still in the early stages of development. Current research must be conducted with the utmost precision.
Source: ReachMD | Aired: May 5, 2008 | Length: 13 min
No comments:
Post a Comment